{
  "pmid": "41604031",
  "title": "Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.",
  "abstract": "Aging and insulin resistance are intertwined factors in the development of metabolic diseases such as type 2 diabetes and cardiovascular disorders. Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promising cardioprotective effects in preclinical and clinical studies of metabolic diseases. Yet, its action on insulin-resistant aged subjects is not clearly defined. This study aimed to investigate the effects of liraglutide on intracellular zinc levels, including its modulation of oxidative stress, mitochondrial function, and Endoplasmic Reticulum (ER) stress in a novel insulin-resistant senescent model. Insulin resistance and senescence were confirmed by reduced glucose uptake and increased β-Galactosidase Staining and increased p-H2A.X (Ser139) levels after 24 h of co-incubation with bovine serum albumin (BSA) conjugated palmitic acid (PA; 50 µM) and 278 mM D-galactose (D-Gal) in human AC16 cells. Our findings showed upregulated expression of ER and mitochondrial proteostasis markers in the early minutes of liraglutide treatment. In addition, chronic but not acute liraglutide treatment significantly increased intracellular zinc levels, accompanied by improved mitochondrial membrane potential and reduced reactive oxygen species in the insulin-resistant senescent model. Casein kinase 2 inhibition completely abolished liraglutide-induced zinc elevation and mitochondrial improvements in the chronic context, highlighting the role of casein kinase 2 in the subcellular signaling of liraglutide. These findings indicate that liraglutide alters intracellular zinc and modulates endoplasmic reticulum-mitochondria communication, giving insight into its therapeutic potential in metabolic cardiomyopathies linked to insulin resistance and aging.",
  "journal": "Cardiovascular toxicology",
  "year": "2026",
  "authors": [
    {
      "lastName": "Hosseinpourshirazi",
      "foreName": "Fatemeh",
      "initials": "F",
      "affiliation": ""
    },
    {
      "lastName": "Mendes",
      "foreName": "Umur D",
      "initials": "UD",
      "affiliation": ""
    },
    {
      "lastName": "Aksoy",
      "foreName": "Zeynep B",
      "initials": "ZB",
      "affiliation": ""
    },
    {
      "lastName": "Aydos",
      "foreName": "Dunya",
      "initials": "D",
      "affiliation": ""
    },
    {
      "lastName": "Sözer",
      "foreName": "Merve",
      "initials": "M",
      "affiliation": ""
    },
    {
      "lastName": "Aljaser",
      "foreName": "Lubne",
      "initials": "L",
      "affiliation": ""
    },
    {
      "lastName": "Gundogdu",
      "foreName": "Manolya",
      "initials": "M",
      "affiliation": ""
    },
    {
      "lastName": "Sık",
      "foreName": "Suatnur",
      "initials": "S",
      "affiliation": ""
    },
    {
      "lastName": "Tuncay",
      "foreName": "Erkan",
      "initials": "E",
      "affiliation": ""
    },
    {
      "lastName": "Turan",
      "foreName": "Belma",
      "initials": "B",
      "affiliation": ""
    },
    {
      "lastName": "Olgar",
      "foreName": "Yusuf",
      "initials": "Y",
      "affiliation": ""
    }
  ],
  "keywords": [
    "Casein kinase",
    "Insulin resistance",
    "Liraglutide",
    "Mitochondrial function",
    "Senescent cardiomyocytes",
    "Zinc homeostasis"
  ],
  "doi": "10.1007/s12012-026-10095-x",
  "pmcId": null,
  "meshTerms": [
    {
      "descriptor": "Liraglutide",
      "qualifiers": [
        "pharmacology"
      ]
    },
    {
      "descriptor": "Myocytes, Cardiac",
      "qualifiers": [
        "drug effects",
        "metabolism",
        "pathology"
      ]
    },
    {
      "descriptor": "Zinc",
      "qualifiers": [
        "metabolism"
      ]
    },
    {
      "descriptor": "Insulin Resistance",
      "qualifiers": []
    },
    {
      "descriptor": "Humans",
      "qualifiers": []
    },
    {
      "descriptor": "Mitochondria, Heart",
      "qualifiers": [
        "drug effects",
        "metabolism",
        "pathology"
      ]
    },
    {
      "descriptor": "Endoplasmic Reticulum Stress",
      "qualifiers": [
        "drug effects"
      ]
    },
    {
      "descriptor": "Cellular Senescence",
      "qualifiers": [
        "drug effects"
      ]
    },
    {
      "descriptor": "Cell Line",
      "qualifiers": []
    },
    {
      "descriptor": "Oxidative Stress",
      "qualifiers": [
        "drug effects"
      ]
    },
    {
      "descriptor": "Membrane Potential, Mitochondrial",
      "qualifiers": [
        "drug effects"
      ]
    },
    {
      "descriptor": "Reactive Oxygen Species",
      "qualifiers": [
        "metabolism"
      ]
    },
    {
      "descriptor": "Hypoglycemic Agents",
      "qualifiers": [
        "pharmacology"
      ]
    },
    {
      "descriptor": "Signal Transduction",
      "qualifiers": []
    }
  ],
  "rawXml": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">41604031</PMID><DateCompleted><Year>2026</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1559-0259</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>2026</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Cardiovascular toxicology</Title><ISOAbbreviation>Cardiovasc Toxicol</ISOAbbreviation></Journal><ArticleTitle>Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.</ArticleTitle><Pagination><StartPage>22</StartPage><MedlinePgn>22</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s12012-026-10095-x</ELocationID><Abstract><AbstractText>Aging and insulin resistance are intertwined factors in the development of metabolic diseases such as type 2 diabetes and cardiovascular disorders. Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promising cardioprotective effects in preclinical and clinical studies of metabolic diseases. Yet, its action on insulin-resistant aged subjects is not clearly defined. This study aimed to investigate the effects of liraglutide on intracellular zinc levels, including its modulation of oxidative stress, mitochondrial function, and Endoplasmic Reticulum (ER) stress in a novel insulin-resistant senescent model. Insulin resistance and senescence were confirmed by reduced glucose uptake and increased &#x3b2;-Galactosidase Staining and increased p-H2A.X (Ser139) levels after 24&#xa0;h of co-incubation with bovine serum albumin (BSA) conjugated palmitic acid (PA; 50 &#xb5;M) and 278 mM D-galactose (D-Gal) in human AC16 cells. Our findings showed upregulated expression of ER and mitochondrial proteostasis markers in the early minutes of liraglutide treatment. In addition, chronic but not acute liraglutide treatment significantly increased intracellular zinc levels, accompanied by improved mitochondrial membrane potential and reduced reactive oxygen species in the insulin-resistant senescent model. Casein kinase 2 inhibition completely abolished liraglutide-induced zinc elevation and mitochondrial improvements in the chronic context, highlighting the role of casein kinase 2 in the subcellular signaling of liraglutide. These findings indicate that liraglutide alters intracellular zinc and modulates endoplasmic reticulum-mitochondria communication, giving insight into its therapeutic potential in metabolic cardiomyopathies linked to insulin resistance and aging.</AbstractText><CopyrightInformation>&#xa9; 2026. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Hosseinpourshirazi</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mendes</LastName><ForeName>Umur D</ForeName><Initials>UD</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmacology, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aksoy</LastName><ForeName>Zeynep B</ForeName><Initials>ZB</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aydos</LastName><ForeName>Dunya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>S&#xf6;zer</LastName><ForeName>Merve</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmacology, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aljaser</LastName><ForeName>Lubne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Interdisciplinary Food, Metabolism and Clinical Nutrition Department, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gundogdu</LastName><ForeName>Manolya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Biophysics, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>S&#x131;k</LastName><ForeName>Suatnur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Biophysics, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tuncay</LastName><ForeName>Erkan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Biophysics, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Turan</LastName><ForeName>Belma</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Biophysics, Lokman Hekim University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Olgar</LastName><ForeName>Yusuf</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Biophysics, Ankara University, Ankara, Turkey. yolgar@ankara.edu.tr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2026</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Toxicol</MedlineTA><NlmUniqueID>101135818</NlmUniqueID><ISSNLinking>1530-7905</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>839I73S42A</RegistryNumber><NameOfSubstance UI=\"D000069450\">Liraglutide</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI=\"D015032\">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017382\">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D007004\">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000069450\" MajorTopicYN=\"Y\">Liraglutide</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D032383\" MajorTopicYN=\"Y\">Myocytes, Cardiac</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015032\" MajorTopicYN=\"Y\">Zinc</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007333\" MajorTopicYN=\"Y\">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008929\" MajorTopicYN=\"Y\">Mitochondria, Heart</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D059865\" MajorTopicYN=\"N\">Endoplasmic Reticulum Stress</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016922\" MajorTopicYN=\"Y\">Cellular Senescence</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002460\" MajorTopicYN=\"N\">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018384\" MajorTopicYN=\"N\">Oxidative Stress</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053078\" MajorTopicYN=\"N\">Membrane Potential, Mitochondrial</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017382\" MajorTopicYN=\"N\">Reactive Oxygen Species</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007004\" MajorTopicYN=\"Y\">Hypoglycemic Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Casein kinase</Keyword><Keyword MajorTopicYN=\"N\">Insulin resistance</Keyword><Keyword MajorTopicYN=\"N\">Liraglutide</Keyword><Keyword MajorTopicYN=\"N\">Mitochondrial function</Keyword><Keyword MajorTopicYN=\"N\">Senescent cardiomyocytes</Keyword><Keyword MajorTopicYN=\"N\">Zinc homeostasis</Keyword></KeywordList><CoiStatement>Declarations. Competing Interests: The authors declare no competing interests. Informed Consent: All authors involved in the study accept the contents of the manuscript and consent to its submission.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2026</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>13</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">41604031</ArticleId><ArticleId IdType=\"doi\">10.1007/s12012-026-10095-x</ArticleId><ArticleId IdType=\"pii\">10.1007/s12012-026-10095-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans, J. L., &amp; Goldfine, I. D. (2013). Aging and insulin resistance: Just say iNOS. Diabetes, 62, 346&#x2013;348.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23349542</ArticleId><ArticleId IdType=\"pmc\">3554381</ArticleId><ArticleId IdType=\"doi\">10.2337/db12-1239</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudina, S. (2013). Cardiac aging and insulin resistance: Could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target? Current Pharmaceutical Design, 19, 5684&#x2013;5694.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23448491</ArticleId><ArticleId IdType=\"pmc\">3883087</ArticleId><ArticleId IdType=\"doi\">10.2174/1381612811319320004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, D. F., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., &amp; Rabinovitch, P. S. (2014). Mitochondrial oxidative stress in aging and healthspan. Longevity &amp; Healthspan, 3, 6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/2046-2395-3-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Escriva, F., Gavete, M. L., Fermin, Y., Perez, C., Gallardo, N., Alvarez, C., Andres, A., Ros, M., &amp; Carrascosa, J. M. (2007). Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: Role of adiposity. The Journal of Endocrinology, 194, 131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17592027</ArticleId><ArticleId IdType=\"doi\">10.1677/joe.1.07043</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., &amp; Shulman, G. I. (2003). Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science, 300, 1140&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12750520</ArticleId><ArticleId IdType=\"pmc\">3004429</ArticleId><ArticleId IdType=\"doi\">10.1126/science.1082889</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink, R. I., Kolterman, O. G., Griffin, J., &amp; Olefsky, J. M. (1983). Mechanisms of insulin resistance in aging. Journal of Clinical Investigation, 71, 1523&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6345584</ArticleId><ArticleId IdType=\"pmc\">370358</ArticleId><ArticleId IdType=\"doi\">10.1172/JCI110908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnefsky, E. J., Chen, Q., &amp; Hoppel, C. L. (2016). Mitochondrial metabolism in aging heart. Circulation Research, 118, 1593&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27174952</ArticleId><ArticleId IdType=\"pmc\">5009371</ArticleId><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.116.307505</ArticleId></ArticleIdList></Reference><Reference><Citation>Terzioglu, M., &amp; Larsson, N. G. (2007). Mitochondrial dysfunction in mammalian ageing. Novartis Foundation Symposium, 287, 197&#x2013;208. discussion 208&#x2009;&#x2212;&#x2009;113.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18074640</ArticleId><ArticleId IdType=\"doi\">10.1002/9780470725207.ch14</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan, B., Durak, A., Olgar, Y., &amp; Tuncay, E. (2022). Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction. Molecular and Cellular Biochemistry, 477, 2609&#x2013;2625.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35598217</ArticleId><ArticleId IdType=\"doi\">10.1007/s11010-022-04474-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath, M. Y., &amp; Burcelin, R. (2013). GLP-1 effects on islets: Hormonal, neuronal, or paracrine? Diabetes Care, 36, Article S145.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23882039</ArticleId><ArticleId IdType=\"pmc\">3920778</ArticleId><ArticleId IdType=\"doi\">10.2337/dcS13-2015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Jiang, J., Xu, J., Chen, J., Gu, Y., &amp; Wu, G. (2024). Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes. BMC Musculoskeletal Disorders, 25, Article 601.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39080620</ArticleId><ArticleId IdType=\"pmc\">11287913</ArticleId><ArticleId IdType=\"doi\">10.1186/s12891-024-07640-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, X.-J., Hao, J.-T., Zheng, R.-H., Yan, C.-P., Wang, J., Yang, C.-H., Zhang, W.-F., &amp; Zhao, Z.-Q. (2021). Glucagon-like peptide-1 analog liraglutide attenuates pressure-overload induced cardiac hypertrophy and apoptosis through activating ATP sensitive potassium channels. Cardiovascular Drugs and Therapy, 35, 87&#x2013;101.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33057968</ArticleId><ArticleId IdType=\"doi\">10.1007/s10557-020-07088-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagaki, T., Michael, M., &amp; H&#xf6;lscher, C. (2017). Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells. Scientific Reports, 7, Article 16158.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29170452</ArticleId><ArticleId IdType=\"pmc\">5700973</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-017-16488-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantadosi, C. A., &amp; Suliman, H. B. (2012). Redox regulation of mitochondrial biogenesis. Free Radical Biology and Medicine, 53, 2043&#x2013;2053.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23000245</ArticleId><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2012.09.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Gorlach, A., Kietzmann, T., Kubaichuk, K., Knaus, U. G., Lopez, M. G., Olaso-Gonzalez, G., Petry, A., Schulz, R., Vina, J., Winyard, P., Abbas, K., Ademowo, O. S., Afonso, C. B., Andreadou, I., Antelmann, H.,&#xa0;&#x2026; &amp;&#xa0;Daiber, A. (2017). European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox biology 13: 94&#x2013;162.</Citation></Reference><Reference><Citation>Makrecka-Kuka, M., Liepinsh, E., Murray, A. J., Lemieux, H., Dambrova, M., Tepp, K., Puurand, M., K&#xe4;&#xe4;mbre, T., Han, W. H., de Goe, P., O&#x2019;Brien, K. A., Turan, B., Tuncay, E., Olgar, Y., Rolo, A. P., Palmeira, C. M., Boardman, N. T., W&#xfc;st, R. C. I., &amp; Larsen, T. S. (2020). Altered mitochondrial metabolism in the insulin-resistant heart. Acta Physiologica (Oxford, England), 228, Article e13430.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31840389</ArticleId><ArticleId IdType=\"doi\">10.1111/apha.13430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamanaka, R. B., &amp; Chandel, N. S. (2010). Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences, 35, 505&#x2013;513.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20430626</ArticleId><ArticleId IdType=\"pmc\">2933303</ArticleId><ArticleId IdType=\"doi\">10.1016/j.tibs.2010.04.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, S. S., &amp; Kaufman, R. J. (2014). Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxidants &amp; Redox Signaling, 21, 396&#x2013;413.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2014.5851</ArticleId></ArticleIdList></Reference><Reference><Citation>Olgar, Y., Tuncay, E., Degirmenci, S., Billur, D., Dhingra, R., Kirshenbaum, L., &amp; Turan, B. (2020). Ageing-associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca(2+) homeostasis and promotes cardiac dysfunction. Journal of Cellular and Molecular Medicine, 24, 8567&#x2013;8578.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32652890</ArticleId><ArticleId IdType=\"pmc\">7412693</ArticleId><ArticleId IdType=\"doi\">10.1111/jcmm.15483</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioi, T., &amp; Inuzuka, Y. (2012). Aging as a substrate of heart failure. Journal of Cardiology, 60, 423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23068289</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jjcc.2012.07.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukada, T., &amp; Kambe, T. (2018). Welcome to the world of zinc signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19030785</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms19030785</ArticleId><ArticleId IdType=\"pubmed\">29522449</ArticleId><ArticleId IdType=\"pmc\">5877646</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi, S., Adulcikas, J., Sohal, S. S., &amp; Myers, S. (2017). Zinc transporters and insulin resistance: Therapeutic implications for type 2 diabetes and metabolic disease. Journal of Biomedical Science, 24, 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-017-0394-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan, B., Billur, D. and Olgar, Y. (2019). Zinc signaling in aging heart function. Zinc Signaling: 139&#x2013;164.</Citation></Reference><Reference><Citation>Cabrera, A. J. (2015). Zinc, aging, and immunosenescence: An overview. Pathobiology of Aging &amp; Age Related Diseases, 5, Article 25592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3402/pba.v5.25592</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan, B., &amp; Tuncay, E. (2017). Impact of labile zinc on heart function: From physiology to pathophysiology. Int J Mol Sci, 18, 2395.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29137144</ArticleId><ArticleId IdType=\"pmc\">5713363</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms18112395</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Q., Yang, Q., Guo, P., Feng, Y., Wang, S., Guo, J., Tang, Z., Yu, W., &amp; Liao, J. (2023). Mitophagy contributes to zinc-induced ferroptosis in porcine testis cells. Food and Chemical Toxicology, 179, Article 113950.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37481227</ArticleId><ArticleId IdType=\"doi\">10.1016/j.fct.2023.113950</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Q., Fang, Y., Zhang, C., Liu, X., Wu, Y., Zhang, Y., Yang, J., &amp; Yong, K. (2022). Exposure to zinc induces lysosomal-mitochondrial axis-mediated apoptosis in PK-15 cells. Ecotoxicology and Environmental Safety, 241, Article 113716.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35667309</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ecoenv.2022.113716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y., Wang, P., Guo, J., Ma, T., Hu, Y., Huang, L., Xing, B., He, Y., &amp; Xi, J. (2023). Zinc overload induces damage to h9c2 cardiomyocyte through mitochondrial dysfunction and ros-mediated mitophagy. Cardiovascular Toxicology, 23, 388&#x2013;405.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37845565</ArticleId><ArticleId IdType=\"doi\">10.1007/s12012-023-09811-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarosz, M., Olbert, M., Wyszogrodzka, G., M&#x142;yniec, K., &amp; Librowski, T. (2017). Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-&#x3ba;B signaling. Inflammopharmacology, 25, 11&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28083748</ArticleId><ArticleId IdType=\"pmc\">5306179</ArticleId><ArticleId IdType=\"doi\">10.1007/s10787-017-0309-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig, B., Meerarani, P., Toborek, M., &amp; McClain, C. J. (1999). Antioxidant-like properties of zinc in activated endothelial cells. Journal of the American College of Nutrition, 18, 152&#x2013;158.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10204831</ArticleId><ArticleId IdType=\"doi\">10.1080/07315724.1999.10718843</ArticleId></ArticleIdList></Reference><Reference><Citation>Maret, W. (2000). The function of zinc metallothionein: A link between cellular zinc and redox state. Journal of Nutrition, 130, 1455S-1458S.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10801959</ArticleId><ArticleId IdType=\"doi\">10.1093/jn/130.5.1455S</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson, M. M., Nesti, C., Palenzuela, L., Walker, W. F., Hernandez, E., Protas, L., Hirano, M., &amp; Isaac, N. D. (2005). Novel cell lines derived from adult human ventricular cardiomyocytes. Journal of Molecular and Cellular Cardiology, 39, 133&#x2013;147.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15913645</ArticleId><ArticleId IdType=\"doi\">10.1016/j.yjmcc.2005.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada, K., Nakata, M., Horimoto, N., Saito, M., Matsuoka, H., &amp; Inagaki, N. (2000). Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic beta-cells. The Journal of Biological Chemistry, 275, 22278&#x2013;22283.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10748091</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M908048199</ArticleId></ArticleIdList></Reference><Reference><Citation>Olgar, Y., Durak, A., &amp; Turan, B. (2025). Acute GLP-1 agonism induces arrhythmogenic electrical activity in aged mice heart through impaired cellular Na&#x2009;+&#x2009;and Ca2&#x2009;+&#x2009;handlings: The role of CK2 hyperphosphorylation. Anatolian Journal of Cardiology, 29, 83.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39655941</ArticleId><ArticleId IdType=\"pmc\">11793800</ArticleId><ArticleId IdType=\"doi\">10.14744/AnatolJCardiol.2024.4719</ArticleId></ArticleIdList></Reference><Reference><Citation>Olgar, Y., Billur, D., Tuncay, E., &amp; Turan, B. (2020). MitoTEMPO provides an antiarrhythmic effect in aged-rats through attenuation of mitochondrial reactive oxygen species. Experimental Gerontology, 136, Article 110961.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32325093</ArticleId><ArticleId IdType=\"doi\">10.1016/j.exger.2020.110961</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydos, D., Aksoy, Z. B., Unal, M. A., Akcali, K. C., Bitirim, C. V., &amp; Turan, B. (2025). The dual GLP-1 and GIP receptor agonist tirzapetide provides an unintended interaction with the &#x3b2;-adrenoceptors and plays a role in glucose metabolism in hyperglycemic or senescent cardiac cells. Cardiovascular Diabetology, 24, Article 338.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">40826463</ArticleId><ArticleId IdType=\"pmc\">12362930</ArticleId><ArticleId IdType=\"doi\">10.1186/s12933-025-02828-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Endt, H., Sprung, C. N., Keller, U., Gaipl, U., Fietkau, R., &amp; Distel, L. V. (2010). Detailed analysis of DNA repair and senescence marker kinetics over the life span of a human fibroblast cell line. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 66A, 367&#x2013;375.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glq197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantar-Gok, D., Hidisoglu, E., Er, H., Acun, A. D., Olgar, Y., &amp; Yarg&#x131;coglu, P. (2017). Changes of auditory event-related potentials in ovariectomized rats injected with d-galactose: Protective role of rosmarinic acid. Neurotoxicology, 62, 64&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28501655</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuro.2017.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnahdi, A., John, A., &amp; Raza, H. (2019). Augmentation of glucotoxicity, oxidative stress, apoptosis and mitochondrial dysfunction in HepG2 cells by palmitic acid. Nutrients, 11, Article 1979.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31443411</ArticleId><ArticleId IdType=\"pmc\">6770774</ArticleId><ArticleId IdType=\"doi\">10.3390/nu11091979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai, S., Kokubu, D., Mizukami, H., &amp; Itoh, K. (2023). Mitochondrial reactive oxygen species, insulin resistance, and Nrf2-mediated oxidative stress response&#x2014;Toward an actionable strategy for anti-aging. Biomolecules, 13, Article 1544.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37892226</ArticleId><ArticleId IdType=\"pmc\">10605809</ArticleId><ArticleId IdType=\"doi\">10.3390/biom13101544</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Zhou, H., Wu, W., Shi, C., Hu, S., Yin, T., Ma, Q., Han, T., Zhang, Y., &amp; Tian, F. (2016). Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+&#x2013;XO&#x2013;ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radical Biology and Medicine, 95, 278&#x2013;292.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27038735</ArticleId><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2016.03.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, A., Chen, Z., Xia, Y., Lu, D., Yang, X., Sun, A., Zou, Y., Qian, J., &amp; Ge, J. (2018). Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells. Biochemical and Biophysical Research Communications, 499, 267&#x2013;272.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29571736</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbrc.2018.03.142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirim, C. V., Tuncay, E., &amp; Turan, B. (2018). Demonstration of subcellular migration of CK2&#x3b1; localization from nucleus to sarco (endo) plasmic reticulum in mammalian cardiomyocytes under hyperglycemia. Molecular and Cellular Biochemistry, 443, 25&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29058176</ArticleId><ArticleId IdType=\"doi\">10.1007/s11010-017-3207-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, K. M., Kille, P., &amp; Hogstrand, C. (2012). Protein kinase CK2 opens the gate for zinc signaling. Cell Cycle, 11, 1863&#x2013;1864.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22580452</ArticleId><ArticleId IdType=\"pmc\">3359116</ArticleId><ArticleId IdType=\"doi\">10.4161/cc.20414</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi, M., Trashi, E., Cozza, G., Negro, A., Hanson, P., &amp; Pinna, L. (2012). Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases. BioTechniques, 53, 9&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2144/000113866</ArticleId></ArticleIdList></Reference><Reference><Citation>Durak, A., &amp; Turan, B. (2023). Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts. Journal of Physiology and Biochemistry, 79, 297&#x2013;311.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36515811</ArticleId><ArticleId IdType=\"doi\">10.1007/s13105-022-00939-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Maret, W., &amp; Kr&#x119;&#x17c;el, A. (2007). Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Molecular Medicine, 13, 371&#x2013;375.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17622324</ArticleId><ArticleId IdType=\"pmc\">1952669</ArticleId><ArticleId IdType=\"doi\">10.2119/2007-00036.Maret</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. J., &amp; Wu, M. J. (2016). The new role for an old kinase: Protein kinase CK2 regulates metal ion transport. Pharmaceuticals, 9, Article 80.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28009816</ArticleId><ArticleId IdType=\"pmc\">5198054</ArticleId><ArticleId IdType=\"doi\">10.3390/ph9040080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathaway, G. M., &amp; Traugh, J. A. (1984). Interaction of polyamines and magnesium with casein kinase II. Archives of Biochemistry and Biophysics, 233, 133&#x2013;138.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6331801</ArticleId><ArticleId IdType=\"doi\">10.1016/0003-9861(84)90609-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuncay, E., Bitirim, V. C., Durak, A., Carrat, G. R. J., Taylor, K. M., Rutter, G. A., &amp; Turan, B. (2017). Hyperglycemia-induced changes in ZIP7 and ZnT7 expression cause Zn(2+) release from the sarco(endo)plasmic reticulum and mediate ER stress in the heart. Diabetes, 66, 1346&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28232492</ArticleId><ArticleId IdType=\"doi\">10.2337/db16-1099</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, K. M., Hiscox, S., Nicholson, R. I., Hogstrand, C., &amp; Kille, P. (2012). Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Science Signaling, 5, Article ra11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22317921</ArticleId><ArticleId IdType=\"pmc\">3428905</ArticleId><ArticleId IdType=\"doi\">10.1126/scisignal.2002585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuncay, E., Olgar, Y., Aryan, L., &#x15e;&#x131;k, S., Billur, D., &amp; Turan, B. (2025). ZnT6-mediated Zn2&#x2009;+&#x2009;redistribution: Impact on mitochondrial fission and autophagy in H9c2 cells. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-025-05247-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11010-025-05247-6</ArticleId><ArticleId IdType=\"pubmed\">40087209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz, C., &amp; Papa, F. R. (2018). The unfolded protein response and cell fate control. Molecular Cell, 69, 169&#x2013;181.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29107536</ArticleId><ArticleId IdType=\"doi\">10.1016/j.molcel.2017.06.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, Y., Wang, Z., Ma, B., Fan, L., Yi, N., Lu, B., Wang, Q., &amp; Liu, R. (2018). GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress. Frontiers in Pharmacology, 9, Article 1168.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30459598</ArticleId><ArticleId IdType=\"pmc\">6232689</ArticleId><ArticleId IdType=\"doi\">10.3389/fphar.2018.01168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, R., Vinod, V., Symons, J. D., &amp; Boudina, S. (2020). Protein and mitochondria quality control mechanisms and cardiac aging. Cells, 9, Article 933.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32290135</ArticleId><ArticleId IdType=\"pmc\">7226975</ArticleId><ArticleId IdType=\"doi\">10.3390/cells9040933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanagat, J., &amp; Hevener, A. L. (2016). Mitochondrial quality control in insulin resistance and diabetes. Current Opinion in Genetics &amp; Development, 38, 118&#x2013;126.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gde.2016.05.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H., Xiao, C., Zhao, Y., Yin, H., &amp; Yu, M. (2021). Liraglutide improves endothelial function via the mTOR signaling pathway. Journal of Diabetes Research, 2021, Article 2936667.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34447854</ArticleId><ArticleId IdType=\"pmc\">8384515</ArticleId><ArticleId IdType=\"doi\">10.1155/2021/2936667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>",
  "fetched_at": "2026-01-29T18:50:49.289Z"
}